Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-25

FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal Pharmaceuticals LLC's supplemental application for a generic buprenorphine HCl and naloxone HCl product for the treatment of opioid use diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine HCl and Naloxone HCl (Buprenorphine and Naloxone)

Snippet

SUPPL AP for BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE)